136 related articles for article (PubMed ID: 7815644)
1. From the Food and Drug Administration.
Nightingale SL
JAMA; 1995 Jan; 273(4):279. PubMed ID: 7815644
[No Abstract] [Full Text] [Related]
2. Warnings for health care products: a communication perspective.
Mundt J; Driver RW
Health Mark Q; 1994; 12(2):55-75. PubMed ID: 10141085
[No Abstract] [Full Text] [Related]
3. Flight 483 now boarding.
Czap A
Altern Med Rev; 2010 Sep; 15(3):183-5. PubMed ID: 21155619
[No Abstract] [Full Text] [Related]
4. From the Food and Drug Administration.
Nightingale SL
JAMA; 1996 Sep; 276(10):774. PubMed ID: 8769577
[No Abstract] [Full Text] [Related]
5. The issue of extralabel drug use.
Kennedy JA
J Am Vet Med Assoc; 1997 Dec; 211(11):1354. PubMed ID: 9394877
[No Abstract] [Full Text] [Related]
6. Going global. FDA moves to deal with growing raft of imports.
Lee J
Mod Healthc; 2011 Jun; 41(26):16. PubMed ID: 21853607
[No Abstract] [Full Text] [Related]
7. Efficacy of labeling of foods and pharmaceuticals.
Viscusi WK
Annu Rev Public Health; 1994; 15():325-43. PubMed ID: 8054088
[No Abstract] [Full Text] [Related]
8. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.
Green W
Food Drug Law J; 1995; 50(4):553-67. PubMed ID: 10343019
[No Abstract] [Full Text] [Related]
9. Unknown safety profile of ingredients in hair supplements: A call to action for improved patient safety.
Pathoulas JT; Bellefeuille G; Lofgreen SJ; Shaik J; Hordinsky MK; Sadick NS; Farah RS
J Am Acad Dermatol; 2020 Sep; 83(3):e213-e214. PubMed ID: 32417421
[No Abstract] [Full Text] [Related]
10. New (still proposed) rules for sunscreen. UVA testing and ranking may be the most important change.
Harv Health Lett; 2010 Jun; 35(8):6. PubMed ID: 20700956
[No Abstract] [Full Text] [Related]
11. Protecting the consumer from getting burned: the FDA, the administrative process, and the tentative final monograph on over-the-counter sunscreens.
Jones PR
Am J Law Med; 1994; 20(3):317-35. PubMed ID: 7702077
[No Abstract] [Full Text] [Related]
12. Patient package inserts: the proper prescription?
Rowe HM
Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
[No Abstract] [Full Text] [Related]
13. Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program.
Epstein MS; Shah ED; Deepak P; Kushnir VM
Am J Gastroenterol; 2019 Jul; 114(7):1017-1019. PubMed ID: 31033521
[No Abstract] [Full Text] [Related]
14. The regulation of biotechnologies: four recommendations.
Fox D
Hastings Cent Rep; 2008; 38(2):1 p following 56. PubMed ID: 18457229
[No Abstract] [Full Text] [Related]
15. Children, drugs, and the Food and Drug Administration: studies of pediatric drugs are beginning to catch up.
Ward RM
Pediatr Ann; 2001 Apr; 30(4):189-94. PubMed ID: 11303433
[No Abstract] [Full Text] [Related]
16. FDA prohibits extralabel use of two drug classes.
J Am Vet Med Assoc; 1997 Aug; 211(3):269. PubMed ID: 9262656
[No Abstract] [Full Text] [Related]
17. Lessons from cisapride.
CMAJ; 2001 May; 164(9):1269, 1271. PubMed ID: 11341130
[No Abstract] [Full Text] [Related]
18. Refurbished medical equipment.
Donawa ME
Med Device Technol; 1998 Apr; 9(3):12-5. PubMed ID: 10179194
[TBL] [Abstract][Full Text] [Related]
19. Adverse Events Reported to the US Food and Drug Administration for Cosmetics and Personal Care Products.
Kwa M; Welty LJ; Xu S
JAMA Intern Med; 2017 Aug; 177(8):1202-1204. PubMed ID: 28654953
[TBL] [Abstract][Full Text] [Related]
20. The FDA: A tough tonic.
Wadman M
Nature; 2009 Nov; 462(7272):406-7. PubMed ID: 19940894
[No Abstract] [Full Text] [Related]
[Next] [New Search]
